Nos publications
Mise à jour novembre 2023
Pagination
- Page précédente
- Page 7
- Page suivante
Title | Authors | Year | Journal | Link to Article | Intended Audience Trier par ordre croissant | Purpose |
---|---|---|---|---|---|---|
Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Hematopoietic progenitor cells (HPC), cord blood | Jenkins C | 2020 | Blood.ca website | View Circular of information for the use of human blood components: Hematopoietic progenitor cells (HPC), cord blood | Health care providers | Benchmarking and standard setting |
Postnatal intervention for the treatment of FNAIT: a systematic review | Baker JM, Shehata N, Bussel J, Murphy MF, Greinacher A, Bakchoul T, Massey E, Lieberman L, Landry D, Tanael S, Arnold DM, Baidya S, Bertrand G, Kjaer M, Kaplan C, Kjeldsen-Kragh J, Oepkes D, Savoia H, Ryan G, Hume H, On behalf of the International Collaboration for Transfusion Medicine Guidelines (ICTMG) | 2019 | J Perinatol | View Postnatal intervention for the treatment of FNAIT: a systematic review | Health care providers | Clinical research |
Système Lewis : les anticorps anti-Lewis | Peng S, Meunier D | 2019 | Blood.ca website | View Système Lewis : les anticorps anti-Lewis | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC), Cord Blood | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
FAQ: Canadian Blood Services Platelet Bacterial Testing | Khandelwal A, Ramirez-Arcos S, Bigham M | 2021 | Blood.ca website | View FAQ: Canadian Blood Services Platelet Bacterial Testing | Health care providers | Other |
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura | Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, Matsumoto M, Mustafa RA, Pai M, Rock G, Russell L, Tarawneh R, Valdes J, Peyvandi F | 2020 | J Thromb Haemost | View ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura | Health care providers | Benchmarking and standard setting |
Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia | Nazy I, Jevtic SD, Moore JC, Huynh A, Smith JW, Kelton JG, Arnold DM | 2021 | J Thromb Haemost | View Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia | Health care providers | Clinical research |
Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk | Shih AW, Yan MTS, Elahie AL, Barty RL, Liu Y, Berardi P, Azzam M, Siddiqui R, Parvizian MK, Mcdougall T, Heddle NM, Al-Habsi KS, Goldman M, Cote J, Athale U, Verhovsek MM | 2020 | Transfus Med | View Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk | Health care providers | Clinical research |
Rejuvenated and safe: Freeze-dried plasma for the 21st century | Sheffield WP, V. Devine D | 2022 | Transfusion | View Rejuvenated and safe: Freeze-dried plasma for the 21st century | Health care providers | New or improved product or process |
Chapter 2: Blood components | Gupta A, Bigham M | 2021 | Clinical Guide to Transfusion | View Chapter 2: Blood components | Health care providers | Benchmarking and standard setting |
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma | Estcourt LJ, Cohn CS, Pagano MB, Iannizzi C, Kreuzberger N, Skoetz N, Allen ES, Bloch EM, Beaudoin G, Casadevall A, Devine DV, Foroutan F, Gniadek TJ, Goel R, Gorlin J, Grossman BJ, Joyner MJ, Metcalf RA, Raval JS, Rice TW, Shaz BH, Vassallo RR, Winters JL, Tobian AAR | 2022 | Ann Intern Med | View Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma | Health care providers | Benchmarking and standard setting |
Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia | Nazy I, Kelton JG, Moore JC, Clare R, Horsewood P, Smith JW, Ivetic N, D'Souza V, Li N, Arnold DM | 2018 | Br J Haematol | View Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia | Health care providers | Clinical research |
Blood and clots series: Which antithrombotic therapy should I start for my patient with acute VTE? | Tseng E | 2018 | CanadiEM website | View Blood and clots series: Which antithrombotic therapy should I start for my patient with acute VTE? | Health care providers | Benchmarking and standard setting |
Design and Implementation of a Competency-Based Transfusion Medicine Training Program in Canada | Zeller MP, Sherbino J, Whitman L, Skeate R, Arnold DM | 2016 | Transfus Med Rev | View Design and Implementation of a Competency-Based Transfusion Medicine Training Program in Canada | Health care providers | Other |
Does Age of Blood Matter? It Depends | Hebert PC, Tinmouth A | 2015 | Am J Respir Crit Care Med | View Does Age of Blood Matter? It Depends | Health care providers | Other |
Evaluation and Management of Proteinuria After Kidney Transplantation | Tsampalieros A, Knoll GA | 2015 | Transplantation | View Evaluation and Management of Proteinuria After Kidney Transplantation | Health care providers | Clinical research |
HbM methaemoglobinaemia as a rare case of early neonatal benign cyanosis | Elboraee MS, Clarke G, Belletrutti MJ, Escoredo S | 2015 | BMJ Case Reports | View HbM methaemoglobinaemia as a rare case of early neonatal benign cyanosis | Health care providers | Clinical research |
In reply to 'dialysis vintage could confound survival trends in ESRD patients' | van Walraven C, Manuel D, Knoll G | 2014 | Am J Kidney Dis | View In reply to 'dialysis vintage could confound survival trends in ESRD patients' | Health care providers | Other |
Neonatal and pediatric transfusion | Lau W | 2017 | Clinical Guide to Transfusion | View Neonatal and pediatric transfusion | Health care providers | Benchmarking and standard setting |
Plasma transfusion trials and tribulations | Shih A, Arnold DM | 2015 | Transfusion | View Plasma transfusion trials and tribulations | Health care providers | Clinical research |
The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis | Rimmer E, Houston BL, Kumar A, Abou-Setta AM, Friesen C, Marshall JC, Rock G, Turgeon AF, Cook DJ, Houston DS, Zarychanski R | 2014 | Crit Care | View The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis | Health care providers | Clinical research |
What should men living with haemophilia need to know? The perspectives of Canadian men with haemophilia | Arnold E, Lane S, Webert KE, Chan A, Walker I, Tufts J, Rubin S, Poon MC, Heddle NM | 2014 | Haemophilia | View What should men living with haemophilia need to know? The perspectives of Canadian men with haemophilia | Health care providers | Other |
Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Carter RLR, Talbot K, Hur WS, Meixner SC, Van Der Gugten JG, Holmes DT, Côté HCF, Kastrup CJ, Smith TW, Lee AYY, Pryzdial ELG | 2018 | J Thromb Haemost | View Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Health care providers | Basic research |
Safeguarding the Patient's Own Blood Supply | Zeller MP, Kaufman RM | 2019 | JAMA | View Safeguarding the Patient's Own Blood Supply | Health care providers | Clinical research |
Concentré de recherche: Transfusion de culots globulaires?: lien entre la non-concordance des sexes et la mortalité | Zeller M | 2019 | Blood.ca website | View Concentré de recherche: Transfusion de culots globulaires?: lien entre la non-concordance des sexes et la mortalité | Health care providers | Clinical research |
GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks | Foroutan F, Guyatt G, Zuk V, Vandvik PO, Alba AC, Mustafa R, Vernooij R, Arevalo-Rodriguez I, Munn Z, Roshanov P, Riley R, Schandelmaier S, Kuijpers T, Siemieniuk R, Canelo-Aybar C, Schunemann H, Iorio A | 2020 | J Clin Epidemiol | View GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks | Health care providers | Benchmarking and standard setting |
Blood Components | Gupta A, Bigham M | 2020 | Clinical Guide to Transfusion | View Blood Components | Health care providers | Benchmarking and standard setting |
Testing and management of fetal and neonatal alloimmune thrombocytopenia | Meunier D, Clarke G | 2020 | Blood.ca website | View Testing and management of fetal and neonatal alloimmune thrombocytopenia | Health care providers | Benchmarking and standard setting |
Déclaration des réactions transfusionnelles indésirables | Yan M | 2021 | Blood.ca website | View Déclaration des réactions transfusionnelles indésirables | Health care providers | Benchmarking and standard setting |
Implementation of measures to reduce vasovagal reactions: Donor participation and results | Goldman M, Uzicanin S, Marquis-Boyle L, O'Brien SF | 2021 | Transfusion | View Implementation of measures to reduce vasovagal reactions: Donor participation and results | Health care providers | Clinical research |
Blood Donation Testing and the Safety of the Blood Supply | Goldman M, Drews SJ | 2022 | Practical Transfusion Medicine | View Blood Donation Testing and the Safety of the Blood Supply | Health care providers | Benchmarking and standard setting |
FAQ: Canadian Blood Services platelet bacterial screening | Khandelwal A, Ramirez-Arcos S, Bigham M | 2022 | Blood.ca website | View FAQ: Canadian Blood Services platelet bacterial screening | Health care providers | Benchmarking and standard setting |
FAQ : Le sang total déleucocyté à la Société canadienne du sang | Mack J | 2022 | Blood.ca website | View FAQ : Le sang total déleucocyté à la Société canadienne du sang | Health care providers | New or improved product or process |
Circulaire d'information utilisation de composants sanguins humains: Sang total | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Sang total | Health care providers | Benchmarking and standard setting |
A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles | Akyurekli C, Le Y, Richardson RB, Fergusson D, Tay J, Allan DS | 2015 | Stem Cell Rev | View A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles | Health care providers | Clinical research |
Alloimmunization of patients by blood units harboring distinct DEL variants | St-Louis M, Lebrun A, Goldman M, Lavoie M | 2013 | Immunohematology | View Alloimmunization of patients by blood units harboring distinct DEL variants | Health care providers | Clinical research |
Anti-D; a type of IVIg | Khan R, Lazarus A | 2018 | Antibody Therapy: Substitution - Immunomodulation - Monoclonal Immunotherapy | View Anti-D; a type of IVIg | Health care providers | Other |
Blood-Borne Pathogens - A Canadian Blood Services Centre for Innovation Symposium | Walsh GM, Shih AW, Solh Z, Golder M, Schubert P, Fearon M, Sheffield WP | 2016 | Transfus Med Rev | View Blood-Borne Pathogens - A Canadian Blood Services Centre for Innovation Symposium | Health care providers | Other |
Expert approaches to common bleeding and thrombotic problems-part I | Hayward CP, Webert KE | 2012 | Semin Thromb Hemost | View Expert approaches to common bleeding and thrombotic problems-part I | Health care providers | Other |
Modeling of body weight metrics for effective and cost-efficient conventional factor VIII dosing in hemophilia A prophylaxis | McEneny-King A, Chelle P, Henrard S, Hermans C, Iorio A, Edginton AN | 2017 | Pharmaceutics | View Modeling of body weight metrics for effective and cost-efficient conventional factor VIII dosing in hemophilia A prophylaxis | Health care providers | Clinical research |
Peanut and fish allergy due to platelet transfusion in a child | Ching JC, Lau W, Hannach B, Upton JE | 2015 | CMAJ | View Peanut and fish allergy due to platelet transfusion in a child | Health care providers | Clinical research |
Platelet product quality remains high after seven days of storage | Serrano K, Schubert P, Devine D | 2017 | Blood.ca website | View Platelet product quality remains high after seven days of storage | Health care providers | New or improved product or process |
Pre-transfusion testing | Lane D | 2017 | Clinical Guide to Transfusion | View Pre-transfusion testing | Health care providers | Benchmarking and standard setting |
Questioning some recommendations in the umbilical cord blood guideline | Elmoazzen H, Petraszko T | 2018 | J Obstet Gynaecol Can | View Questioning some recommendations in the umbilical cord blood guideline | Health care providers | New or improved product or process |
Risks and trends of red blood cell transfusion in obstetric patients: a retrospective study of 45,213 deliveries using administrative data | Shehata N, Chassé M, Colas JA, Murphy M, Forster AJ, Malinowski AK, Ducharme R, Fergusson DA, Tinmouth A, Wilson K | 2017 | Transfusion | View Risks and trends of red blood cell transfusion in obstetric patients: a retrospective study of 45,213 deliveries using administrative data | Health care providers | Clinical research |
Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review | Poudel DR, Ghimire S, Dhital R, Forman DA, Warkentin TE | 2017 | Platelets | View Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review | Health care providers | Clinical research |
The Stem Cell Club: a model for unrelated stem cell donor recruitment | Fingrut W, Parmar S, Cuperfain A, Rikhraj K, Charman E, Ptak E, Kahlon M, Graham A, Luong S, Wang YG, Yu J, Arora N, Suppiah R, Li EW, Lee A, Welsh C, Benzaquen M, Thatcher A, Baharmand I, Ladd A, Petraszko T, Allan D, Messner H | 2017 | Transfusion | View The Stem Cell Club: a model for unrelated stem cell donor recruitment | Health care providers | New or improved product or process |
Transfusion reactions: prevention, diagnosis, and treatment | Delaney M, Wendel S, Bercovitz RS, Cid J, Cohn C, Dunbar NM, Apelseth TO, Popovsky M, Stanworth SJ, Tinmouth A, Van De Watering L, Waters JH, Yazer M, Ziman A | 2016 | Lancet | View Transfusion reactions: prevention, diagnosis, and treatment | Health care providers | Clinical research |
Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Tinmouth A, Thompson T, Arnold DM, Callum JL, Gagliardi K, Lauzon D, Owens W, Pinkerton P | 2013 | Transfusion | View Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Health care providers | Benchmarking and standard setting |